$24.910
+1.373 (+5.51%)Al cierre
Comparativa sectorial de SPTX
In the context of the broader market, SPTX competes directly with industry leaders such as MLTX and MNKD. With a market capitalization of $1.29B, it holds a significant position in the sector. When comparing efficiency, SPTX's gross margin of N/A stands against MLTX's N/A and MNKD's 69.00%. Such benchmarking helps identify whether Seaport Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Seaport Therapeutics Inc
The company has a current ratio of 18.00, indicating strong liquidity, and total equity increased significantly to $422.6 million in Q2 2026, showing improved financial health.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.